Table 2. Sickle cell disorders—interactions and indications for prenatal diagnosis and preimplantation genetic diagnosis (PGD).
Genotype interaction | Disorder expected | Appropriate to offer PND |
---|---|---|
Homozygous | ||
Hb S | Sickle cell disease | Yes |
Compound heterozygous | ||
Hb S/β° or severe β+-thalassaemia | Sickle cell disease | Yes |
Hb S/mild β+-thalassaemia | Mild sickle cell disease | Occasionallya |
Hb S/δβ°-thalassaemia | Mild sickle cell disease | Occasionallya |
Hb S/Hb Lepore | Mild sickle cell disease | Occasionallya |
Hb S/HbC | Sickle cell disease (variable severity) | Yes |
Hb S/Hb D-Punjab | Sickle cell disease | Yes |
Hb S/Hb O-Arab | Sickle cell disease | Yes |
Hb S/Hbs C-Harlem, S-Southend, S-Antilles | Sickle cell disease | Yes |
Hb C/Hb S-Antilles | Sickle cell disease | Yes |
Hb S/Hbs Quebec-Chori, C-Ndjamena, O-Tibesi | Sickle cell disease | Yes |
Hb S/Hbs I-Toulouse, Shelby, Hope, North Shore | Haemolytic anaemia | No |
Hb S/Hb E | Mild to severe sickle cell disease | Occasionallya |
Hb S/HPFH | Very mild sickle cell disease | No |
Note: The decision to have prenatal diagnosis belongs to the couple, once they have had comprehensive counselling.
Couples with genotypes that may lead to offspring with unpredictable phenotypes occasionally select to have prenatal diagnosis or PGD.